November 22, 2025 a 07:43 am
CI: Fundamental Ratio Analysis - Cigna Corporation
The Cigna Corporation, a robust player in the healthcare sector, continues to demonstrate strong performance with its diversified offerings. With a history tracing back over two centuries, the company remains a key provider of insurance and health-related services. Investors may find Cigna's comprehensive approach and stable fundamentals appealing for long-term investment.
Fundamental Rating
Cigna Corporation shows a solid fundamental standing with its diversified services enhancing overall stability. Below is a breakdown of the latest scores across key financial metrics.
| Category | Score | Representation |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
Historical Rating
Reviewing historical ratings offers insight into Cigna Corporation's consistent performance over time. The snapshot below compares current and past scores.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-11-21 | 4 | 5 | 4 | 5 | 1 | 2 | 3 |
| Previous | 0 | 5 | 4 | 5 | 1 | 2 | 3 |
Analyst Price Targets
Analyst price targets for Cigna provide a practical glimpse into market expectations. The consensus suggests a stable growth outlook.
| High | Low | Median | Consensus |
|---|---|---|---|
| $415 | $294 | $320 | $334.5 |
Analyst Sentiment
Analysts predominantly rate Cigna as a buy, indicating positive investor sentiment driven by the company's performance and strategic positioning.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 29 | |
| Hold | 9 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Cigna Corporation displays strong fundamental metrics and a positive market outlook, supported by favourable analyst ratings. The company's diversification in healthcare services contributes to its resilience and attractiveness. Potential investors should consider the balance between Cigna's growth prospects and any inherent industry risks. Overall, Cigna remains a compelling option for those seeking a stable investment in the healthcare sector. Its historical performance and current market perception reinforce its capacity for continued success.